COVID‐19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS‐CoV‐2 Infection Among Target Groups in Europe, October 2024–January 2025, VEBIS Primary Care Network

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Charlotte Laniece Delaunay, Nuno Verdasca, Susana Monge, Lisa Domegan, Noémie Sève, Silke Buda, Adam Meijer, Héloïse Lucaccioni, Miriam López Torrijos, Adele McKenna, Vincent Enouf, Ralf Dürrwald, Eline In't Velt, Mª Ángel de Valcárcel Laiglesia, Charlene Bennett, Shirley Masse, Annika Erdwiens, Mariette Hooiveld, Ivan Mlinarić, Gergő Túri, Ana Paula Rodrigues, Iván Martínez‐Baz, Mihaela Lazar, Neus Latorre‐Margalef, Vitor Borges, Marlena Kaczmarek, Sabrina Bacci, Esther Kissling
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Influenza and Other Respiratory Viruses
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet